Company: DMAAR
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001213900-25-046061
Chunk: 90

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-05-20
Form: 10-Q
Item: Part I, Item 2
Chunk 90
---
Item 2. Management’s Discussion and Analysis of Financial
Condition and Results of Operations.

References in this report to “we,”
“us,” “our” or the “Company” refer to Drugs Made In America Acquisition Corp. References to our “management”
or our “management team” refer to our officers and directors, and references to the “sponsor” refer to Drugs Made
In America Acquisition LLC. The following discussion and analysis of the Company’s financial condition and results of operations
should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this report. Certain information
contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties

Special Note Regarding Forward-Looking Statements

Some of the statements contained in this report
may constitute “forward-looking statements” for purposes of the federal securities laws. All statements, other than statements
of historical fact included in this report including, without limitation, statements in this “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and
the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,”
“anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions
are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance,
but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events,
performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For
information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking
statements, please refer to the “Risk Factors” section of the Company’s final prospectus for its initial public offering
filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s filings with the SEC can be accessed
on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company
disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future
events or otherwise.

Overview

We are a blank check company incorporated in the
Cayman Islands on May 23, 2024 formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization,
reorganization